RTFCCR/LLS Prevention Information & Policies
A reference page for active Rising Tide Foundation for Clinical Cancer Research / The Leukemia & Lymphoma Society Patient-Focused Prevention grantees
For information about other programs, and about applying for LLS research funding, click here.
Reporting Schedule: Rising Tide Foundation (RTF) grant reporting is conducted through https://proposalcentral.com. Please log in to this site to review RTF's reporting requirements and schedule for your grant. The LLS reporting schedule for your particular grant is also printed on your Grant Agreement and available under Reports Due in the LLS Research Portal (FLUXX).
Report Submission: You can access the LLS Research Portal (FLUXX) using the same username and password that were used during the application process. Individuals responsible for submitting reports must be manually added to each individual grant record in our system in order for them to have reporting access for each grant. Contact firstname.lastname@example.org to update reporting access for your grant.
Progress Reports and Publications Reports should be submitted by the researcher (the PI). Financial Reports should be submitted by the financial officer.
Researchers and administrators should be careful to follow all instructions on the report web form and downloadable template. Reports that fail to follow instructions will be returned for revision, which may delay grant payment. Do not save templates for future use; the templates are subject to change and therefore must be newly downloaded for each submission.
LLS pays research grants quarterly in March, June, September, and December. Payments are contingent upon reporting requirements; all report approvals must be up to date in order for payment to be processed. A list of sent payments can be viewed in the LLS Research Portal (FLUXX) under Dispersed Payments.
LLS and RTF approval is required at least 30 days prior to an award's transfer to a new institution or laboratory. Only one transfer per grant is allowed. In order to submit a request for transfer, complete a Special Requests report in the LLS Research Portal (FLUXX). Your request will be reviewed, and you will receive a notification from LLS with the results of the review or with a request for more information. Approval is contingent upon continued research support and sponsorship, fitness of the new research environment, and circumstances of your award type and timing of the request (see your Grant Agreement for more details).
Transfer to another investigator may be allowed if the original grantee is unable to continue the project (e.g. if they move to a new institution unequipped for the project). Contact email@example.com to inquire about a grantee transfer.
Leaves of Absence
LLS approval is required at least 30 days prior to the interruption of an award. Leaves of absence may not exceed 1 year in duration. In order to submit a request for leave of absence, complete a Special Requests report in the LLS Research Portal (FLUXX). If the request is approved, funding of the award will be suspended during the leave period, and the grant term will be extended for a period equal to the duration of the suspension (e.g. following an approved 1-year leave of absence, an award originally scheduled to end 6/30/2022 will end 6/30/2023).
If you have questions regarding your grant that are not addressed here, please contact the Research Administration Team at firstname.lastname@example.org.